Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 30 results.
User Information
Export Records
  1. 1.   Recent developments in animal venom peptide nanotherapeutics with improved selectivity for cancer cells
  2. Giribaldi,Julien; Smith,Jennifer; Schroeder,Christina
  3. Biotechnology advances. 2021, Sep-Oct; 50
  1. 2.   Custom G4 Microarrays Reveal Selective G-Quadruplex Recognition of Small Molecule BMVC: A Large-Scale Assessment of Ligand Binding Selectivity
  2. Wu, Guanhui; Tillo, Desiree; Ray, Sreejana; Chang, Ta-Chau; Schneekloth,Jay; Vinson, Charles; Yang, Danzhou
  3. Molecules (Basel, Switzerland). 2020, AUG; 25(15): pii: E3465.
  1. 3.   De novo design of selective membrane-active peptides via enzymatic control of their conformational bias on the cell surface
  2. Shi,Junfeng; Schneider,Joel
  3. Angewandte Chemie (International ed. in English). 2019, JUL 26;
  1. 4.   Development of Highly Selective 1,2,3-Triazole-containing Peptidic Polo-like Kinase 1 Polo-box Domain-binding Inhibitors
  2. Zhao,Xue Zhi; Tsuji,Kohei; Hymel, David; Burke,Terrence
  3. MOLECULES. 2019, Apr 16; 24(8):
  1. 5.   Enhancing polo-like kinase 1 selectivity of polo-box domain-binding peptides
  2. Zhao, Xue Zhi; Hymel, David; Burke, Terrence
  3. BIOORGANIC & MEDICINAL CHEMISTRY. 2017, OCT 1; 25(19 Special Issue: SI): 5041-5049.
  1. 6.   Cationic liposomes are possible drug-delivery systems for HIV fusion inhibitor sifuvirtide
  2. Franquelim, H. G.; De-Sousa, F. F.; Veiga, A. S.; Santos, N. C.; Castanho, M.
  3. Soft Matter. 2011, Dec 7; 7(23): 11089-11092.
  1. 7.   Enhanced Stereoselectivity of a Cu(II) Complex Chiral Auxiliary in the Synthesis of Fmoc-L-gamma-carboxyglutamic Acid
  2. Smith, D. J.; Yap, G. P. A.; Kelley, J. A.; Schneider, J. P.
  3. Journal of Organic Chemistry. 2011, Mar; 76(6): 1513-1520.
  1. 8.   Activation of glycosyl trichloroacetimidates with perchloric acid on silica (HClO4-SiO2) provides enhanced alpha-selectivity
  2. Ludek, O. R.; Gu, W. L.; Gildersleeve, J. C.
  3. Carbohydrate Research. 2010, Sep 23; 345(14): 2074-2078.
  1. 9.   Membrane anchoring of diacylglycerol lactones substituted with rigid hydrophobic acyl domains correlates with biological activities
  2. Raifman, O.; Kolusheva, S.; Comin, M. J.; Kedei, N.; Lewin, N. E.; Blumberg, P. M.; Marquez, V. E.; Jelinek, R.
  3. Febs Journal. 2010, Jan; 277(1): 233-243.
  1. 10.   Gene conversion between mammalian CCR2 and CCR5 chemokine receptor genes: A potential mechanism for receptor dimerization
  2. Vazquez-Salat, N.; Yuhki, N.; Beck, T.; O'Brien, S. J.; Murphy, W. J.
  3. Genomics. 2007, Aug; 90(2): 213-224.
  1. 11.   In vitro efficacy of immuno-chemotherapy with anti-EGFR human fab-taxol conjugate on A431 epidermoid carcinoma cells
  2. Wang, X.; Zhu, J.; Zhao, P.; Jiao, Y. G.; Xu, N.; Grabinski, T.; Liu, C.; Miranti, C. K.; Fu, T.; Cao, B. B.
  3. Cancer Biology & Therapy. 2007, Jun; 6(6): 980-986.
  1. 12.   Conformationally constrained analogues of diacylglycerol (DAG). 27. Modulation of membrane translocation of protein kinase C (PKC) isozymes alpha and delta by diacylglycerol lactones (DAG-lactones) containing rigid-rod acyl groups
  2. Malolanarasimhan, K.; Kedei, N.; Sigano, D. M.; Kelley, J. A.; Lai, C. C.; Lewin, N. E.; Surawski, R. J.; Pavlyukovets, V. A.; Garfield, S. H.; Wincovitch, S.; Blumberg, P. M.; Marquez, V. E.
  3. Journal of Medicinal Chemistry. 2007, Mar; 50(5): 962-978.
  1. 13.   Enhancing molecular flux through nanopores by means of attractive interactions
  2. Kasianowicz, J. J.; Nguyen, T. L.; Stanford, V. M.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2006, Aug; 103(31): 11431-11432.
  1. 14.   Carbohydrate array analysis of anti-Tn antibodies and lectins reveals unexpected specificities: Implications for diagnostic and vaccine development
  2. Manimala, J. C.; Li, Z. T.; Jain, A.; VedBrat, S.; Gildersleeve, J. C.
  3. Chembiochem. 2005, DEC; 6(12): 2229-2241.
  1. 15.   Substrate specificity of the human protein phosphatase 2C delta Wip1
  2. Yamaguchi, H.; Minopoli, G.; Demidov, O. N.; Chatterjee, D. K.; Anderson, C. W.; Durell, S. R.; Appella, E.
  3. Biochemistry. 2005, APR 12; 44(14): 5285-5294.
  1. 16.   Utilization of a common pathway for the synthesis of high affinity macrocyclic Grh2 SH2 domain-binding peptide mimetics that differ in the configuration at one ring junction
  2. Shi, Z. D.; Karki, R. G.; Worthy, K. M.; Bindu, L. K.; Nicklaus, M. C.; Fisher, R. J.; Burke, T. R.
  3. Chemistry & Biodiversity. 2005 2(4): 447-456.
  1. 17.   Design and synthesis of novel indole beta-diketo acid derivatives as HIV-1 integrase inhibitors
  2. Sechi, M.; Derudas, M.; Dallocchio, R.; Dessi, A.; Bacchi, A.; Sannia, L.; Carta, F.; Palomba, M.; Ragab, O.; Chan, C.; Shoemaker, R.; Sei, S.; Dayam, R.; Neamati, N.
  3. Journal of Medicinal Chemistry. 2004, OCT 7; 47(21): 5298-5310.
  1. 18.   A 4 '-C-ethynyl-2 ',3 '-dideoxynucleoside analogue highlights the role of the 3 '-OH in anti-HIV active 4 '-C-ethynyl-2 '-deoxy nucleosides
  2. Siddiqui, M. A.; Hughes, S. H.; Boyer, P. L.; Mitsuya, H.; Van, Q. N.; George, C.; Sarafinanos, S. G.; Marquez, V. E.
  3. Journal of Medicinal Chemistry. 2004, OCT 7; 47(21): 5041-5048.
  1. 19.   (Salen)Mn-catalyzed epoxidation of alkenes: A two-zone process with different spin-state channels as suggested by DFT study
  2. Abashkin, Y. G.; Burt, S. K.
  3. Organic Letters. 2004, Jan; 6(1): 59-62.
  1. 20.   Chirality determination of unusual amino acids using precolumn derivatization and liquid chromatography-electrospray ionization mass spectrometry
  2. Hess, S.; Gustafson, K. R.; Milanowski, D. J.; Alvira, E.; Lipton, M. A.; Pannell, L. K.
  3. Journal of Chromatography A. 2004 1035(2): 211-219.
  1. 21.   Rational design and synthesis of novel dimeric diketoacid-containing inhibitors of HIV-1 integrase: Implication for binding to two metal ions on the active site of integrase
  2. Long, Y. Q.; Jiang, X. H.; Dayam, R.; Sanchez, T.; Shoemaker, R.; Sei, S.; Neamati, N.
  3. Journal of Medicinal Chemistry. 2004 47(10): 2561-2573.
  1. 22.   Ultrahigh resolution drug design I: Details of interactions in human aldose reductase-inhibitor complex at 0.66 angstrom
  2. Howard, E. I.; Sanishvili, R.; Cachau, R. E.; Mitschler, A.; Chevrier, B.; Barth, P.; Lamour, V.; Van Zandt, M.; Sibley, E.; Bon, C.; Moras, D.; Schneider, T. R.; Joachimiak, A.; Podjarny, A.
  3. Proteins-Structure Function and Bioinformatics. 2004 55(4): 792-804.
  1. 23.   Cytotoxicity and apoptosis of benzoquinones: redox cycling, cytochrome c release, and BAD protein expression
  2. Tudor, G.; Gutierrez, P.; Aguilera-Gutierrez, A.; Sausville, E. A.
  3. Biochemical Pharmacology. 2003 65(7): 1061-1075.
  1. 24.   Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3
  2. Wu, Z. B.; Hoover, D. M.; Yang, D.; Boulegue, C.; Santamaria, F.; Oppenheim, J. J.; Lubkowski, J.; Lu, W. Y.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2003 100(15): 8880-8885.
  1. 25.   Methanocarba modification of uracil and adenine nucleotides: High potency of northern ring conformation at P2Y(1), P2Y(2), P2Y(4), and P2Y(11) but not P2Y(6) receptors
  2. Kim, H. S.; Ravi, R. G.; Marquez, V. E.; Maddileti, S.; Wihlborg, A. K.; Erlinge, D.; Malmsjo, M.; Boyer, J. L.; Harden, T. K.; Jacobson, K. A.
  3. Journal of Medicinal Chemistry. 2002 45(1): 208-218.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel